AMICOMED provides clinical-grade, easy-to-use and affordable digital health services for consumers. These services are tailored for a consumer user experience without need for professional assistance in the usage, yet scientifically proven and clinically valid.
The first service we are currently offering, targeted at the 1 billion+ people with hypertension in the world, is an innovative service to manage and reduce blood pressure: real time clinically-valid assessment of blood pressure trend, thanks to our medically-certified proprietary algorithm, and a personalised program to master blood pressure based on actionable lifestyle changes without adding medications.
We plan to complement and support physicians, not substitute them and promote the services with a medical high-quality and professional image.
06.10.2017
US accelerator invests in Amicomed (startupticker.ch)
06.10.2017
US accelerator invests in Amicomed (startupticker.ch)
13.02.2017
Amicomed closes seed round (startupticker.ch)
03.08.2016
Amicomed joins Silicon Valley incubator (startupticker.ch)
No milestones
No Jobs
No videos and documents
No Awards
Website:
www.amicomed.com/?lang=en
Headquarter:
Lugano
Foundation Date:
June 2015
Technology:
Sectors: